Article
Real-world clinical analysis in 190 advanced NSCLC patients with uncommon EGFR mutations: A multi-center study.
Cancer science - 1 Jun 2023
Qin Yi, Long Yaling, Tang Yuan, Tian Yuke, Li Juan, Duan Ping, Luo Jieyan, Yu Min, Li Yanying, Zhou Xiaojuan, Wang Ke, Gong Youling, Peng Feng, Zhu Jiang, Liu Yongmei, Zhou Lin, Lu You, Huang Meijuan
Abstract excerpt
Differently from epidermal growth factor receptor (EGFR) 19Del and L858R mutations, the panoramic description of uncommon EGFR mutations is far from mature. Our understanding of its population characteristics, treatment response, and drug resistance mechanisms needs urgent expansion and deepening. Our study enrolled 437 patients with non-small-cell lung cancer from four clinical centers and who had uncommon EGFR...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.